Kansal Mayank M, Mansour Ibrahim N, Ismail Sahar, Bress Adam, Wu Grace, Mirza Omer, Marpadga Rahul, Gheith Hana, Kim Yoonsang, Li Yien, Cavallari Larisa, Stamos Thomas D
Department of Medicine, Division of Cardiology, University of Illinois at Chicago, Chicago, Illinois.
Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
Clin Cardiol. 2017 May;40(5):314-321. doi: 10.1002/clc.22662. Epub 2017 Mar 8.
Several studies have demonstrated the importance of left ventricular (LV) global longitudinal strain (GLS) as a reliable prognostic indicator in patients with heart failure (HF). These studies have included few African American (AA) patients, despite the growing prevalence and severity of HF in this patient population.
LV GLS predicts long-term HF admission and all-cause mortality in AA patients with chronic HF on optimal guideline-directed medical therapy (GDMT).
We enrolled 207 AA adults, age 56 ± 14.5 years, with New York Heart Association (NYHA) class I through III HF on optimal GDMT from the University of Illinois HF clinic between November 2001 and February 2014. LV GLS was assessed by velocity vector imaging using 2-, 3-, and 4-chamber views. Patients were followed for HF admissions and death for 3 ± 3.0 years. LV GLS value of -7.95 was used as the optimal cutoff point that maximizes sensitivity and specificity RESULTS: LV GLS < -7.95% was significantly associated with higher all-cause mortality and HF admissions in Kaplan-Meier survival curves (log-rank P < 0.001). After incorporation in multivariate Cox proportional hazard models, GLS < -7.95% was found to be an independent predictor of all-cause mortality (hazard ratio [HR] = 4.04; 95% confidence interval [CI]: 1.07-15.32; P = 0.04] and HF admissions (HR = 3.86; 95% CI: 1.38-10.77; P = 0.010).
In AA patients with chronic stable HF on GDMT, more impaired LV GLS (< -7.95%) is a strong and independent predictor of long-term all-cause mortality and HF admissions.
多项研究已证明左心室(LV)整体纵向应变(GLS)作为心力衰竭(HF)患者可靠的预后指标的重要性。尽管该患者群体中HF的患病率和严重程度不断上升,但这些研究纳入的非裔美国人(AA)患者很少。
LV GLS可预测接受最佳指南指导药物治疗(GDMT)的AA慢性HF患者的长期HF住院率和全因死亡率。
我们纳入了207名年龄在56±14.5岁之间的AA成年人,他们于2001年11月至2014年2月期间在伊利诺伊大学HF诊所接受最佳GDMT治疗,纽约心脏协会(NYHA)心功能分级为I至III级。通过使用二腔、三腔和四腔视图的速度向量成像评估LV GLS。对患者进行3±3.0年的HF住院和死亡随访。LV GLS值-7.95被用作使敏感性和特异性最大化的最佳截断点。结果:在Kaplan-Meier生存曲线中,LV GLS < -7.95%与更高的全因死亡率和HF住院率显著相关(对数秩P < 0.001)。纳入多变量Cox比例风险模型后,发现GLS < -7.95%是全因死亡率(风险比[HR] = 4.04;95%置信区间[CI]:1.07 - 15.32;P = 0.04)和HF住院率(HR = 3.86;95% CI:1.38 - 10.77;P = 0.010)的独立预测因素。
在接受GDMT的AA慢性稳定HF患者中,更严重受损的LV GLS(< -7.95%)是长期全因死亡率和HF住院率的强有力独立预测因素。